<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>gemfibrozil</title><link>http://www.unboundmedicine.com/medline/ebm/research/gemfibrozil</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_</link><description>Jones PH <br/><span class="title">Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. [Journal Article]</span><br/><span class="source" title="The American journal of cardiology">Am J Cardiol 2008 Dec 22; 102(12A):41L-47L.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19084089/abstract/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19084089/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Find Related Articles</a> </description></item><item><title>Positive relationship between dietary fat, ethanol intake, triglycerides, and hypothalamic peptides: counteraction by lipid-lowering drugs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19801273/full_citation/Positive_relationship_between_dietary_fat_ethanol_intake_triglycerides_and_hypothalamic_peptides:_counteraction_by_lipid_lowering_drugs_</link><description>Barson JR, Karatayev O, Chang GQ, et al. <br/><span class="title">Positive relationship between dietary fat, ethanol intake, triglycerides, and hypothalamic peptides: counteraction by lipid-lowering drugs. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Alcohol (Fayetteville, N.Y.)">Alcohol 2009 Sep; 43(6):433-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19801273/abstract/Positive_relationship_between_dietary_fat_ethanol_intake_triglycerides_and_hypothalamic_peptides:_counteraction_by_lipid_lowering_drugs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19801273/full_citation/Positive_relationship_between_dietary_fat_ethanol_intake_triglycerides_and_hypothalamic_peptides:_counteraction_by_lipid_lowering_drugs_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0741-8329(09)00101-3">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19801273/Positive_relationship_between_dietary_fat_ethanol_intake_triglycerides_and_hypothalamic_peptides:_counteraction_by_lipid_lowering_drugs_">Find Related Articles</a> </description></item><item><title>Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19779008/full_citation/Using_Complementary_and_Alternative_Medicines_to_Target_the_Host_Response_during_Severe_Influenza_</link><description>Alleva LM, Cai C, Clark IA <br/><span class="title">Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza. [JOURNAL ARTICLE]</span><br/><span class="source" title="Evidence-based complementary and alternative medicine : eCAM">Evid Based Complement Alternat Med 2009 Sep 24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19779008/abstract/Using_Complementary_and_Alternative_Medicines_to_Target_the_Host_Response_during_Severe_Influenza_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19779008/full_citation/Using_Complementary_and_Alternative_Medicines_to_Target_the_Host_Response_during_Severe_Influenza_">Full Citation</a></description></item><item><title>The Enterohepatic Disposition of Rosuvastatin in Pigs and The Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19773540/full_citation/The_Enterohepatic_Disposition_of_Rosuvastatin_in_Pigs_and_The_Impact_of_Concomitant_Dosing_with_Cyclosporine_and_Gemfibrozil_</link><description>Bergman E, Lundahl A, Fridblom P, et al. <br/><span class="title">The Enterohepatic Disposition of Rosuvastatin in Pigs and The Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug metabolism and disposition: the biological fate of chemicals">Drug Metab Dispos 2009 Sep 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19773540/abstract/The_Enterohepatic_Disposition_of_Rosuvastatin_in_Pigs_and_The_Impact_of_Concomitant_Dosing_with_Cyclosporine_and_Gemfibrozil_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19773540/full_citation/The_Enterohepatic_Disposition_of_Rosuvastatin_in_Pigs_and_The_Impact_of_Concomitant_Dosing_with_Cyclosporine_and_Gemfibrozil_">Full Citation</a></description></item><item><title>CYP2C8 Activity Recovers Within 96 Hours After Gemfibrozil Dosing: Estimation of CYP2C8 Half-life Using Repaglinide as an In Vivo Probe.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19773535/full_citation/CYP2C8_Activity_Recovers_Within_96_Hours_After_Gemfibrozil_Dosing:_Estimation_of_CYP2C8_Half_life_Using_Repaglinide_as_an_In_Vivo_Probe_</link><description>Backman JT, Honkalammi J, Neuvonen M, et al. <br/><span class="title">CYP2C8 Activity Recovers Within 96 Hours After Gemfibrozil Dosing: Estimation of CYP2C8 Half-life Using Repaglinide as an In Vivo Probe. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug metabolism and disposition: the biological fate of chemicals">Drug Metab Dispos 2009 Sep 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19773535/abstract/CYP2C8_Activity_Recovers_Within_96_Hours_After_Gemfibrozil_Dosing:_Estimation_of_CYP2C8_Half_life_Using_Repaglinide_as_an_In_Vivo_Probe_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19773535/full_citation/CYP2C8_Activity_Recovers_Within_96_Hours_After_Gemfibrozil_Dosing:_Estimation_of_CYP2C8_Half_life_Using_Repaglinide_as_an_In_Vivo_Probe_">Full Citation</a></description></item><item><title>[Facial edema due to gemfibrozil.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19767021/full_citation/[Facial_edema_due_to_gemfibrozil_]</link><description>García Llopis P, González D'huicque A, Palop Larrea V <br/><span class="title">[Facial edema due to gemfibrozil.] [LETTER]</span><br/><span class="source" title="Medicina clinica">Med Clin (Barc) 2009 Sep 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19767021/full_citation/[Facial_edema_due_to_gemfibrozil_]">Full Citation</a></description></item><item><title>Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19756555/full_citation/Rhabdomyolysis_associated_with_fibrate_therapy:_review_of_76_published_cases_and_a_new_case_report_</link><description>Wu J, Song Y, Li H, et al. <br/><span class="title">Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of clinical pharmacology">Eur J Clin Pharmacol 2009 Sep 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19756555/abstract/Rhabdomyolysis_associated_with_fibrate_therapy:_review_of_76_published_cases_and_a_new_case_report_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19756555/full_citation/Rhabdomyolysis_associated_with_fibrate_therapy:_review_of_76_published_cases_and_a_new_case_report_">Full Citation</a></description></item><item><title>Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19734275/full_citation/Gene_expression_profiling_in_rat_liver_treated_with_compounds_inducing_elevation_of_bilirubin_</link><description>Hirode M, Horinouchi A, Uehara T, et al. <br/><span class="title">Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. [JOURNAL ARTICLE]</span><br/><span class="source" title="Human &amp; experimental toxicology">Hum Exp Toxicol 2009 Apr; 28(4):231-244.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19734275/abstract/Gene_expression_profiling_in_rat_liver_treated_with_compounds_inducing_elevation_of_bilirubin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19734275/full_citation/Gene_expression_profiling_in_rat_liver_treated_with_compounds_inducing_elevation_of_bilirubin_">Full Citation</a></description></item><item><title>Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19698935/full_citation/Effect_of_Fibrates_on_Lipid_Profiles_and_Cardiovascular_Outcomes:_A_Systematic_Review_</link><description>Abourbih S, Filion KB, Joseph L, et al. <br/><span class="title">Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review. [JOURNAL ARTICLE]</span><br/><span class="source" title="The American journal of medicine">Am J Med 2009 Aug 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19698935/abstract/Effect_of_Fibrates_on_Lipid_Profiles_and_Cardiovascular_Outcomes:_A_Systematic_Review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19698935/full_citation/Effect_of_Fibrates_on_Lipid_Profiles_and_Cardiovascular_Outcomes:_A_Systematic_Review_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(09)00490-2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19698935/Effect_of_Fibrates_on_Lipid_Profiles_and_Cardiovascular_Outcomes:_A_Systematic_Review_">Find Related Articles</a> </description></item><item><title>Gemfibrozil, stretching arms beyond lipid lowering.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19694602/full_citation/Gemfibrozil_stretching_arms_beyond_lipid_lowering_</link><description>Roy A, Pahan K <br/><span class="title">Gemfibrozil, stretching arms beyond lipid lowering. [Journal Article]</span><br/><span class="source" title="Immunopharmacology and immunotoxicology">Immunopharmacol Immunotoxicol 2009; 31(3):339-51.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19694602/abstract/Gemfibrozil_stretching_arms_beyond_lipid_lowering_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19694602/full_citation/Gemfibrozil_stretching_arms_beyond_lipid_lowering_">Full Citation</a></description></item></channel></rss>